105 related articles for article (PubMed ID: 33870932)
1. LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types.
Zhao GF; Du LQ; Zhang L; Jia YC
Chin Med J (Engl); 2021 Apr; 134(9):1017-1030. PubMed ID: 33870932
[TBL] [Abstract][Full Text] [Related]
2. LMO1 is a novel oncogene in lung cancer, and its overexpression is a new predictive marker for anti-EGFR therapy.
Zhang Y; Yang J; Wang J; Guo H; Jing N
Med Oncol; 2014 Aug; 31(8):99. PubMed ID: 25037573
[TBL] [Abstract][Full Text] [Related]
3. Upregulated LMO1 in prostate cancer acts as a novel coactivator of the androgen receptor.
Gu H; Liu T; Cai X; Tong Y; Li Y; Wang C; Li F
Int J Oncol; 2015 Dec; 47(6):2181-7. PubMed ID: 26459575
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
[TBL] [Abstract][Full Text] [Related]
5. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
6. Indirect Down-regulation of Tumor-suppressive
Saeki N; Saito A; Sugaya Y; Amemiya M; Sasaki H
Cancer Genomics Proteomics; 2018; 15(5):413-420. PubMed ID: 30194082
[TBL] [Abstract][Full Text] [Related]
7. LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.
Zhu S; Zhang X; Weichert-Leahey N; Dong Z; Zhang C; Lopez G; Tao T; He S; Wood AC; Oldridge D; Ung CY; van Ree JH; Khan A; Salazar BM; Lummertz da Rocha E; Zimmerman MW; Guo F; Cao H; Hou X; Weroha SJ; Perez-Atayde AR; Neuberg DS; Meves A; McNiven MA; van Deursen JM; Li H; Maris JM; Look AT
Cancer Cell; 2017 Sep; 32(3):310-323.e5. PubMed ID: 28867147
[TBL] [Abstract][Full Text] [Related]
8. LIM-domain-only proteins in cancer.
Matthews JM; Lester K; Joseph S; Curtis DJ
Nat Rev Cancer; 2013 Feb; 13(2):111-22. PubMed ID: 23303138
[TBL] [Abstract][Full Text] [Related]
9. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
10. Chromatin Immunoprecipitation and DNA Sequencing Identified a LIMS1/ILK Pathway Regulated by LMO1 in Neuroblastoma.
Saeki N; Saito A; Sugaya Y; Amemiya M; Ono H; Komatsuzaki R; Yanagihara K; Sasaki H
Cancer Genomics Proteomics; 2018; 15(3):165-174. PubMed ID: 29695398
[TBL] [Abstract][Full Text] [Related]
11. APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
Li Z; Abraham BJ; Berezovskaya A; Farah N; Liu Y; Leon T; Fielding A; Tan SH; Sanda T; Weintraub AS; Li B; Shen S; Zhang J; Mansour MR; Young RA; Look AT
Leukemia; 2017 Oct; 31(10):2057-2064. PubMed ID: 28260788
[TBL] [Abstract][Full Text] [Related]
12. Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.
Oram SH; Thoms J; Sive JI; Calero-Nieto FJ; Kinston SJ; Schütte J; Knezevic K; Lock RB; Pimanda JE; Göttgens B
Leukemia; 2013 Jun; 27(6):1348-57. PubMed ID: 23302769
[TBL] [Abstract][Full Text] [Related]
13. LIM-domain-only proteins: multifunctional nuclear transcription coregulators that interacts with diverse proteins.
Sang M; Ma L; Sang M; Zhou X; Gao W; Geng C
Mol Biol Rep; 2014 Feb; 41(2):1067-73. PubMed ID: 24379077
[TBL] [Abstract][Full Text] [Related]
14. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Lmo4 gene encoding a LIM-only protein: genomic organization and comparative chromosomal mapping.
Tse E; Grutz G; Garner AA; Ramsey Y; Carter NP; Copeland N; Gilbert DJ; Jenkins NA; Agulnick A; Forster A; Rabbitts TH
Mamm Genome; 1999 Nov; 10(11):1089-94. PubMed ID: 10556429
[TBL] [Abstract][Full Text] [Related]
16. FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-β1 induced LMO1 via control of let-7 expression.
Wang XH; Wu HY; Gao J; Wang XH; Gao TH; Zhang SF
Brain Res; 2019 Feb; 1704():219-228. PubMed ID: 30321496
[TBL] [Abstract][Full Text] [Related]
17. Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
Tse E; Smith AJ; Hunt S; Lavenir I; Forster A; Warren AJ; Grutz G; Foroni L; Carlton MB; Colledge WH; Boehm T; Rabbitts TH
Mol Cell Biol; 2004 Mar; 24(5):2063-73. PubMed ID: 14966285
[TBL] [Abstract][Full Text] [Related]
18. The highly related LIM factors, LMO1, LMO3 and LMO4, play different roles in the regulation of the pituitary glycoprotein hormone alpha-subunit (alpha GSU) gene.
Susa T; Ishikawa A; Cai LY; Kato T; Matsumoto K; Kitahara K; Kurokawa R; Ono T; Kato Y
Biosci Rep; 2009 Oct; 30(1):51-8. PubMed ID: 19228115
[TBL] [Abstract][Full Text] [Related]
19. LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.
Liu J; Yan P; Jing N; Yang J
Tumour Biol; 2014 Aug; 35(8):8161-7. PubMed ID: 24845030
[TBL] [Abstract][Full Text] [Related]
20. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
